![]() New Tools & Methods to accelerate Analytical & Characterization of Biotherapeutics.Driving innovative drugs into clinical success.Antibody-based Immunotherapies : next-generation strategies and approaches.Intellectual Property : Where do we go from now.Innovative Approaches and New trend Technologies.Adoptive cell therapy & Gene Editing : latest advancements.IO Novel mAb target – BsAbs – Fc-fusion protein/ Rare diseases. ![]() This year’s 2-days-programme is organized into 9 tracks covering the hot topics in antibody, cell & gene therapy and other biopharmaceuticals research and development: ![]() The Scientific committee has set-up an exciting program, with keynote lectures, pitch talks around new creative projects, and industrial talks from big pharmaceutical companies. The AIS2022 is the ideal conference for scientists, industrials, physicians and policy makers to exchange about therapeutic antibodies and more! It is part of the series of Industrial Symposia organized by MAbImprove since 2013, whose previous topics were: Antibodies Biosimilars, MAbDosing, MAbDelivery, Current & Next Generation Antibody Formats, Antibody Drug Conjugates, Targets for Mabs, Harnessing the Immune System with Abs, and Multispecific Abs, Ab-like molecules and adoptive cell therapy for fighting diseases. This international congress is jointly organized by the scientific society LabEx MAbImprove and the industrial organization MabDesign. ![]() We are proud to announce the 10th Antibody Industrial Symposium 2022 (AIS2022) that will be held from 28th to 29th June 2022 in person in Montpellier, France. Welcome to the 10th AIS 2022 Antibody Industrial Symposium 2022
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |